Medium materiality6/10
Lucid Capital Markets Starts Eloxx Pharma (ELOX) at Buy
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
bullish
What happened, with direct paths to the underlying reporting
Loop Capital Markets initiates Eloxx Pharma with a Buy rating; target $38; current price $18.16; price change since signal -0.63.
Target: $38
Posted price: $18.16
Analyst firm: Loop Capital Markets
Analyst: Dev Prasad
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.